e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Diffuse parenchymal lung disease III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Unusual multisystemic relapse of sarcoidosis after corticosteroids withdrawal
M. Sponholz Araujo, D. Antunes Silva Pereira, B. Guedes Baldi, C. Salim Gonçalves Freitas, C. Madeira Padovesi, R. Adib Kairalla, C. Roberto Ribeiro Carvalho (São Paulo, Brazil)
Source:
Annual Congress 2013 –Diffuse parenchymal lung disease III
Session:
Diffuse parenchymal lung disease III
Session type:
Thematic Poster Session
Number:
3805
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sponholz Araujo, D. Antunes Silva Pereira, B. Guedes Baldi, C. Salim Gonçalves Freitas, C. Madeira Padovesi, R. Adib Kairalla, C. Roberto Ribeiro Carvalho (São Paulo, Brazil). Unusual multisystemic relapse of sarcoidosis after corticosteroids withdrawal. Eur Respir J 2013; 42: Suppl. 57, 3805
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Are there any predictors of MTX response in progressive pulmonary sarcoidosis?
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Sarcoidosis, a systemic disease
Source: Annual Congress 2005 - Sarcoidosis: update on extrathoracic organ problems
Year: 2005
Sarcoidosis: pulmonary manifestations and management
Source: Eur Respir Monogr 2019; 86: 404-418
Year: 2019
Does concomitant extrapulmonary involvement changes characteristic features of pulmonary sarcoidosis?
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Sarcoidosis
Source: Respipedia Article
Year: 2017
Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Extrapulmonary involvement in sarcoidosis patients
Source: International Congress 2014 – ILDs 4
Year: 2014
Childhood pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Chronic granulomatous disease diagnosed in adulthood- Report of 2 Cases
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Manifestations of malignancies during the course of sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Corticosteroid treatment in sarcoidosis
Source: Eur Respir J 2006; 28: 627-636
Year: 2006
Sarcoidosis relapses in corticosteroid treated patients
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012
How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Pulmonary manifestations of systemic vasculitis in childhood
Source: Breathe, 16 (4) 200211; 10.1183/20734735.0211-2020
Year: 2020
Videothoracoscopy in the differential diagnosis disseminated pulmonary diseases
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016
Methotrexate (MTX) as a single agent for treating chronic, progressive sarcoidosis
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Relapse after discontinuation of infliximab in sarcoidosis patients can be predicted by PET-scan and sIL-2R
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013
Systemic manifestations of sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept